Perioperative hypertension
Stem
A 63-year-old man, 104 kg, is scheduled for elective total knee arthroplasty under general anesthesia. He takes metoprolol, amlodipine and lisinopril for hypertension and clonidine added last year. His creatinine and ECG are normal and he has no angina or heart failure. In the holding area his pressure is 172/102 and heart rate 64; he is anxious and has not slept.
Question
Do you proceed, which of his medications should he have taken, and how will you manage his blood pressure during the case?
Ideal answer
HeadlineI proceed: this looks like anxiety on top of chronic hypertension, below 180/110 with no end-organ injury. He should have taken everything except the lisinopril.
- Exclude other causes first: pain, anxiety, a full bladder, hypoxia, hypercarbia, withdrawal, pheochromocytoma or raised intracranial pressure.
- Proceed below 180/110 without end-organ injury, because delay for moderate hypertension does not improve outcome; at or above it before the day, I consider postponing for gradual control.1
- Metoprolol, amlodipine and clonidine taken; lisinopril held 24 hours, for controlled hypertension, limiting intraoperative hypotension.1
- Blunt laryngoscopy; mean pressure at least 60–65 mmHg1 and within about 20% of his baseline, because his autoregulation curve is shifted right.
- For spikes, deepen anesthesia and give analgesia first, because stimulation is the usual cause; then short-acting titratable drugs.
Watch for: vasoplegia after induction if he took lisinopril this morning; vasopressin ready.
Breaking down the answer
- The 180/110 threshold — above it lability, ischemia and stroke rise, so elective cases wait. Changes if urgent: short-acting agents and go ahead, because delay is riskier than the pressure. Examiners test whether I separate a number from a risk.
- Continue beta-blockers — withdrawal causes rebound tachycardia and ischemia; I do not start a new beta-blocker on the day of surgery, because POISE showed more stroke and death; if one is newly indicated it is started at least 8 days beforehand.1
- Hold ACE inhibitors and ARBs — they cause vasoplegia under anesthesia that responds poorly to phenylephrine; I continue them in heart failure with reduced ejection fraction when the pressure tolerates it.1
- Clonidine rebound — stopping it abruptly causes rebound typically 18–24 hours later, above 1 mg/day,2 so he takes the morning dose with a sip; if he will be NPO for days, the patch is started 2–3 days ahead or overlapped with oral doses.3
- Blunt laryngoscopy — the pressor response is greatest in untreated hypertensives; I use an adequate propofol dose, fentanyl 2–3 mcg/kg, esmolol 0.5–1 mg/kg or lidocaine, and limit laryngoscopy time.
- Which drug for a spike — light anesthesia is the commonest cause, so I deepen first; then labetalol 5–10 mg, esmolol, or nicardipine or clevidipine infusions when I need tight control without slowing the heart.
- Baseline, not normal — a chronically hypertensive brain and kidney lose perfusion at pressures a normotensive patient tolerates, so I never chase a normal number.
Follow-up question
In recovery his pressure is 210/115 with a heart rate of 50, and he is confused. What do you do?
Follow-up answer
HeadlineHypertension with bradycardia and confusion is not pain: it points to raised intracranial pressure or a reflex response. I tell the surgeon.
I check oxygenation, CO2, glucose and pupils, and get a head CT. Were he awake, tachycardic and shivering with a distended bladder, I would treat the cause first: catheterize and give analgesia. Either way, I titrate labetalol or nicardipine to a modest reduction of about 20–25% in mean pressure over the first hour or two, because dropping it fast risks watershed ischemia.4 I reassess for ischemia with an ECG and troponin if there is chest pain or new ST changes, and I confirm he received his clonidine, because rebound is on my list.
Pitfalls that cost points
- Cancelling for a pressure of 160/95 in an anxious patient with no end-organ disease.
- Lowering a chronically hypertensive patient to "normal" and calling the resulting oliguria or confusion unexplained.
- Forgetting pheochromocytoma when hypertension is paroxysmal with headache and sweating.
Rapid-fire
Q: Why is the autoregulation curve shifted right? A: Chronic hypertension thickens arteriolar walls, so the lower limit of cerebral and renal autoregulation rises and these organs need a higher pressure to stay perfused.
Q: Why esmolol for laryngoscopy? A: Onset in about a minute and a half-life of about nine minutes match the brief stimulus, so I avoid post-intubation hypotension.
Q: Why clevidipine over nitroprusside? A: Ultra-short-acting, purely arterial, cleared by blood esterases whatever the renal or hepatic function, with no cyanide toxicity or coronary steal;4 nitroprusside is associated with higher mortality than the alternatives.4
Q: Why does an ARB cause refractory hypotension? A: With angiotensin blocked and sympathetic tone reduced by anesthesia, vasopressin is the remaining pressor system, so small doses of vasopressin work when phenylephrine fails.
Numbers to know
| Item | Value |
|---|---|
| Consider delaying elective surgery | ≥180/110 mmHg1 |
| Intraoperative target | MAP ≥60–65 mmHg or SBP ≥90,1 and within ~20% of baseline |
| Hypertensive emergency | Lower MAP 20–25% over 1–2 h4 |
| Labetalol | 5–20 mg IV, repeat every 10 min |
| Esmolol bolus | 0.5–1 mg/kg IV |
| Nicardipine infusion | 5–15 mg/h |
| Clevidipine infusion | 1–2 mg/h start, double every 90 s |
Links
- Preoperative cardiac evaluation for non-cardiac surgery, Perioperative myocardial ischemia and infarction, Intraoperative hypotension: differential and management, pheochromocytoma, Vasopressors and inotropes: choosing and titrating
- ACC/AHA Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery (2024)
- ACC/AHA Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults
Sources
- 1.2024 ACC/AHA guideline on perioperative cardiovascular management before noncardiac surgery: What's new? · Cleveland Clinic Journal of Medicine, 2025 · ccjm.orgCohn SL, CCJM 92(4), April 2025. Review of the 2024 AHA/ACC guideline; the primary guideline text (ahajournals/jacc) was not reachable from the fetcher.
- 2.Perioperative hypertension management · Vascular Health and Risk Management (Varon, Marik), 2008 · europepmc.orgClonidine withdrawal syndrome typically 18-24 hours after sudden discontinuation in patients taking more than 1.0 mg/day; prevented by converting to a patch.
- 3.Catapres-TTS (clonidine transdermal system) prescribing information · FDA label via Drugs.com · drugs.comTherapeutic plasma levels 2-3 days after initial application; should not be interrupted during the surgical period; prior oral therapy may need to continue during transition.
- 4.Hypertensive Emergencies · Merck Manual Professional Edition · merckmanuals.com
Facts on this page were checked against these sources on Oct 14, 2026. Guidelines change; confirm doses against current institutional protocols.